Shinhan Financial, support for overseas training for young people with disabilities 1,100and the Financial Services Commission, etc. 4on-site disclosure of results (7month 10day)
7month 10on day, Shinhan Financial announced overseas training support for young people with disabilities. The Ministry of Food and Drug Safety approved the imported rare drug 'Joenjajeong.' Chungju City and IBK Bank signed an agreement on preferential interest rates for secondary financing support for small and medium-sized enterprises, and Kyobo Securities held a management strategy meeting for the second half of the year and a 'Vision 1,100',2030declaration ceremony.
Shinhan Financial announced that it will provide overseas training opportunities to young people with disabilities 7month 10day, for young people with disabilities. For investors, the key point is that a financial company’s social contribution activities can affect disclosures and its reputation.1,100.
The launch ceremony was held at Glad Hotel in Yeouido, Seoul. Shinhan Financial said it has run this program together with the Korea Association of Rehabilitation for the Disabled since 2005.
The Ministry of Food and Drug Safety approved the imported rare drug 'Joenjajeong' (reniolisiphosphate) 7month 10day. The product was classified as a rare drug that had received imported product approval.
Chungbuk Chungju City7 in 10signed a 'preferred interest rate for subordinated-interest loan agreement' with IBK Industrial Bank of Korea to ease the financing burden on local SMEs. The agreement centers on preferential loan rates for SMEs based in the region.
KyoBo Securities on the same day in Yeouido, Seoul2026 held its management strategy meeting for the second half of the year and the 'Vision 2030' proclamation ceremony. The company disclosed that it shared its long-term vision and second-half strategy at the event.
This disclosure was concentrated on 7 and 10day, and news related to finance, healthcare, and local governments were announced at the same time. The detailed terms and follow-up disclosures for each announcement are scheduled to be disclosed additionally by each company.